On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Targos Molecular Pathology GmbH's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€365k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- EPIDIACANPartner
Development of sensitive methodologies for exploitation of early epigenetic marker diagnosis in major types of cancer
FP7 (2007 to 2013) · 2010–2012 · Project on CORDIS ↗
€365ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Universitaetsklinikum FreiburgGermany · 1 shared project
- Centre Europeen de Recherche en Biologie et en MedecineFrance · 1 shared project
- Erevnitiko Kentro Vioiatrikon Epistimon Alexandros FlemingkGreece · 1 shared project
- Ethniko Idryma ErevnonGreece · 1 shared project
- Instituto Portugues de Oncologia do Porto Francisco Gentil, EpePortugal · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- colorectal cancer
- enzymes
- mortality
- mutation
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.